Fortress Biotech, Inc. (FBIO) Operating income 2016–2025
Fortress Biotech, Inc. (FBIO) annual operating income history from SEC filings — each fiscal year as reported.
-$70.2MFY2025 · since FY2016: -$65.7M → -$70.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$70.2M | +36.4% |
| FY2024 | -$110.4M | +22.5% |
| FY2023 | -$142.3M | +30.1% |
| FY2022 | -$203.6M | -8.0% |
| FY2021 | -$188.5M | -100.0% |
| FY2020 | -$94.3M | +14.9% |
| FY2019 | -$110.8M | +7.6% |
| FY2018 | -$120.0M | -33.6% |
| FY2017 | -$89.8M | -36.7% |
| FY2016 | -$65.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FBIO financial trends
FBIO RevenueFBIO Net incomeFBIO Net marginFBIO Gross profitFBIO Gross marginFBIO Operating marginFBIO Operating cash flowFBIO Free cash flowFBIO Capital expendituresFBIO Return on equityFBIO Stock buybacksFBIO Dividends paidFBIO Total assetsFBIO Total liabilitiesFBIO Shareholders’ equityFBIO overview →